Kolexia
Hummelsberger Michael Oncologie hémato.
Hummelsberger Michael
Oncologie hémato.
Polycl Champeau Beziers
Béziers, France
29 Activités
321 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'anus Carcinome épidermoïde Neutropénie Hépatite Mélanome {{person.topmesh7.name}} {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Brel Didier
Brel Didier
Inopath, Vernouillet, France
Michel Jacques
Michel Jacques
Hôpital Saint-Éloi, Montpellier, France
Creoff Morgane
Creoff Morgane
Polycl Champeau Beziers, Béziers, France
Pommier Pascal
Pommier Pascal
Ico - Site Paul Papin, Angers, France

Industries

Voir plus
MSD
3 collaboration(s)
Dernière en 2023
AstraZeneca
2 collaboration(s)
Dernière en 2023
Kappa Santé
1 collaboration(s)
Dernière en 2021
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
British journal of cancer   06 janvier 2024
Combination immune checkpoint therapy carried on despite grade 4 immune-related hepatotoxicity during treatment of metastatic melanoma: Case report and review of literature.
Clinics and research in hepatology and gastroenterology   09 août 2023
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   21 février 2023
429P Management of localized anal cancer and prognostic factors in the elderly: Results of the French multicenter cohort FFCD – ANABASE
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Granocyte-colony stimulating factor (G-CSF) has significant efficacy as secondary prophylaxis of chemotherapy-induced neutropenia in patients with solid tumors: results of a prospective study.
Anticancer research   30 mai 2013
{{person.lastact6.name}}
{{person.lastact6.jour}}   {{person.lastact6.date}}
{{person.lastact7.name}}
{{person.lastact7.jour}}   {{person.lastact7.date}}
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}